Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
24 September 2025
Cancers | Prostate Cancer Awareness Month
September is designated as Prostate Cancer Awareness Month, with various global activities that highlight and increase awareness of prostate cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of prostate cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.
The list of relevant papers can be seen below:
“Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer”
by Qiao-Hong Chen, Erick Munoz and Dennis Ashong
Cancers 2024, 16(3), 663; https://doi.org/10.3390/cancers16030663
Available online: https://www.mdpi.com/2072-6694/16/3/663
“Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review”
by Shigekatsu Maekawa, Ryo Takata and Wataru Obara
Cancers 2024, 16(3), 523; https://doi.org/10.3390/cancers16030523
Available online: https://www.mdpi.com/2072-6694/16/3/523
“Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review”
by Georgios Feretzakis, Patrick Juliebø-Jones, Arman Tsaturyan, Tarik Emre Sener, Vassilios S. Verykios, Dimitrios Karapiperis, Themistoklis Bellos, Stamatios Katsimperis, Panagiotis Angelopoulos, Ioannis Varkarakis et al.
Cancers 2024, 16(4), 810; https://doi.org/10.3390/cancers16040810
Available online: https://www.mdpi.com/2072-6694/16/4/810
“Robot-Assisted Radical Prostatectomy by the Hugo Robotic-Assisted Surgery (RAS) System and the da Vinci System: A Comparison between the Two Platforms”
by Hsien-Che Ou, Lucian Marian, Ching-Chia Li, Yung-Shun Juan, Min-Che Tung, Hung-Jen Shih, Chin-Po Chang, Jian-Ting Chen, Che-Hsueh Yang and Yen-Chuan Ou
Cancers 2024, 16(6), 1207; https://doi.org/10.3390/cancers16061207
Available online: https://www.mdpi.com/2072-6694/16/6/1207
“Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center”
by Angelo Totaro, Eros Scarciglia, Filippo Marino, Marco Campetella, Carlo Gandi, Mauro Ragonese, Riccardo Bientinesi, Giuseppe Palermo, Francesco Pio Bizzarri, Antonio Cretì et al.
Cancers 2024, 16(8), 1602; https://doi.org/10.3390/cancers16081602
Available online: https://www.mdpi.com/2072-6694/16/8/1602
“Transperineal Laser Ablation (TPLA) Treatment of Focal Low–Intermediate Risk Prostate Cancer”
by Gugliemo Manenti, Tommaso Perretta, Marco Nezzo, Federico Romeo Fraioli, Beatrice Carreri, Paola Elda Gigliotti, Andrea Micillo, Andrea Malizia, Daniele Di Giovanni, Colleen Patricia Ryan et al.
Cancers 2024, 16(7), 1404; https://doi.org/10.3390/cancers16071404
Available online: https://www.mdpi.com/2072-6694/16/7/1404
“From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer”
by Abdulrahman Alhajahjeh, Raad Al-Faouri, Hisham F. Bahmad, Taima’ Bader, Ryan W. Dobbs, Ahmed A. Abdulelah, Wassim Abou-Kheir, Elai Davicioni, David I. Lee and Mohammed Shahait
Cancers 2024, 16(8), 1538; https://doi.org/10.3390/cancers16081538
Available online: https://www.mdpi.com/2072-6694/16/8/1538
“Glutamine Metabolism and Prostate Cancer”
by Holger H. H. Erb, Nikita Polishchuk, Oleh Stasyk, Uğur Kahya, Matthias M. Weigel and Anna Dubrovska
Cancers 2024, 16(16), 2871; https://doi.org/10.3390/cancers16162871
Available online: https://www.mdpi.com/2072-6694/16/16/2871
“Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review”
by José Pedro Sequeira, Sofia Salta, Rui Freitas, Rafael López-López, Ángel Díaz-Lagares, Rui Henrique and Carmen Jerónimo
Cancers 2024, 16(7), 1363; https://doi.org/10.3390/cancers16071363
Available online: https://www.mdpi.com/2072-6694/16/7/1363
“From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer”
by Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Deya’ Aldeen Sweedat, Stephan Maus, Ula Al-Rasheed, Samer Salah, Fadi Khriesh, Diyaa Juaidi, Dina Abu Dayek, Feras Istatieh et al.
Cancers 2024, 16(11), 1974; https://doi.org/10.3390/cancers16111974
Available online: https://www.mdpi.com/2072-6694/16/11/1974
You are welcome to submit relevant papers to the journal Cancers.
Cancers Editorial Office
